Koninklijke Philips Corporation N.V.

Respironics, Inc.

Ric Investments, Inc.

Respironics Respiratory Drug Delivery (uk) Ltd

Respironics Respiratory Drug Delivery

Ivan Prince

Jonathan S H Denyer

Anthony Dyche

Ian Philip Rabbetts

Neal McLoughlin

Andrew David Mitchell

Ian Thomas Petherbridge

Jeffrey Andrew Pipe

Michael James Robert Leppard

Louise Jane Rowe

Portable nebulizer

The invention relates to a control device () for a medical aerosol delivery device (), a medical aerosol delivery system (), a method for controlling a medical aerosol delivery device (), a computer program element for controlling such device or system, and a computer readable medium having stored such computer program element. The control device () for a medical aerosol delivery device () comprises a provision unit (), a processing unit (), and a control unit (). The provision unit () is configured to provide inhalation length data per breath. The processing unit () is configured to compare the provided inhalation length data with a predetermined inhalation length threshold, and to filter provided inhalation length data below the predetermined inhalation length threshold. The control unit () is configured to control the medical aerosol delivery device () based on the filtered inhalation length data.

Control device for a medical aerosol delivery device

The invention relates to a control device () for a medical aerosol delivery device (), a medical aerosol delivery system, a method for controlling a medical aerosol delivery device (), a computer program element for controlling such device or system, and a computer readable medium having stored such computer program element. The control device is configured to provide inhalation length data and to select an aerosol delivery mode from at least a first aerosol delivery mode or a different, second aerosol delivery mode based on the provided inhalation length data. The first aerosol delivery mode and the different, second aerosol delivery mode are one of a target inhalation mode, a tidal breathing mode, a continuous aerosol delivery mode and breath-actuated delivery mode. Optionally, the control device () comprises a provision unit () and a control unit (). The provision unit () is configured to provide inhalation length data. The processing unit may be configured to select either a first aerosol delivery mode or a different, second aerosol delivery mode based on the provided inhalation length data. The medical aerosol delivery system comprises an aerosol delivery device () and such control device (). The control device () is configured to control the aerosol delivery device (). The aerosol delivery device () is configured to deliver aerosol to a user.

Therapy regimes of a plurality of subjects are remotely monitored and/or managed, wherein the therapy regimes include reception of aerosolized medicament. This enables users such as medical care providers, researchers, clinic administrators, and/or other users to monitor and/or manage the therapy regimes of the plurality of subjects through a centralized access point. This reduces physical requirements of proximity for the users and/or the subjects, alleviates the administrative the burden placed on the users to manage and/or monitor individual therapy regimes, and/or provides other enhancements over convention systems.

System and method of remotely monitoring and/or managing the treatment of a plurality of subjects with aerosolized medicament

A drug delivery apparatus includes a mouthpiece portion having an internal conduit for delivering an aerosol including the drug to the patient. The internal conduit has an inlet end and a mouthpiece end that is structured to be received in the patient's mouth. The mouthpiece portion is structured to operate at a substantially fixed inhalation flow rate when the patient inhales through the mouthpiece end. The apparatus further includes an aerosol generator for generating the aerosol from a drug supply and injecting the aerosol into a first region within the mouthpiece portion located between an outlet of the aerosol generator and the inlet end of the conduit. The mouthpiece portion also includes a flow accelerating mechanism that causes a localized flow rate at the first region to be greater than the inhalation flow rate. A method is also provided that increases the local flow rate within the mouthpiece portion.

Drug delivery apparatus and method

A drug delivery apparatus of the type which releases a drug in aerosolized form into the inhaled airstream of a person, programmed to release the drug in a pulse which ends a pre-set time before the person is expected to stop inhaling. In doing so, a minimum residence time within the lungs is created, and drug treatment time can be reduced. A corresponding method of controlling a drug delivery apparatus comprises the step of controlling the apparatus to release the drug in aerosolized form into the inhaled airstream of a person in a pulse which ends a pre-set time before the person is expected to stop inhaling.

Inhalation method and apparatus

The delivery of a medicament to a mechanically ventilated patient may include the steps of delivering a respiratory maneuver to such a patient, monitoring the physiological effects of the respiratory maneuver on such patient, automatically establishing an adjustment to the respiratory maneuver in response to the monitored physiological effects, and delivering the adjusted respiratory maneuver to such a patient.

Ventilator aerosol delivery

An aerosol drug delivery apparatus is provided. The apparatus may include a reservoir constructed to contain a predetermined dose of a liquid drug, an aerosol generator in communication with the reservoir, and a power source arranged to deliver power to the aerosol generator in order to produce an aerosolized form of the dose that can be administered to a patient. The apparatus may maintain consistent aerosol drug delivery treatments, for example, by way of a breath measuring mechanism that monitors the patient's breathing pattern during the administration of the dose and a controller configured to vary the power level at which the power source during the administration of the dose based on the monitored breathing pattern.

Apparatus and method for maintaining consistency for aerosol drug delivery treatments

Signals may be generated in a drug delivering apparatus through which a person inhales to generate a inhaled airstream to signal to the person to cease inhalation after a pre-set period of time has elapsed from detection of the commencement breathing by that person. The pre-set period of time for subsequent inhalations is adjusted depending on the time the person takes to stop inhaling after being signalled.

Growing community of inventors

Chichester, United Kingdom

Ivan Prince